Literature DB >> 23904767

Canadian integrative oncology research priorities: results of a consensus-building process.

L C Weeks1, D Seely, L G Balneaves, H S Boon, A Leis, D Oneschuk, S M Sagar, M J Verhoef.   

Abstract

BACKGROUND: In Canada, many diverse models of integrative oncology care have emerged in response to the growing number of cancer patients who combine complementary therapies with their conventional medical treatments. The increasing interest in integrative oncology emphasizes the need to engage stakeholders and to work toward consensus on research priorities and a collaborative research agenda. The Integrative Canadian Oncology Research Initiative initiated a consensus-building process to meet that need and to develop an action plan that will implement a Canadian research agenda.
METHODS: A two-day consensus workshop was held after completion of a Delphi survey and stakeholder interviews.
RESULTS: FIVE INTERRELATED PRIORITY RESEARCH AREAS WERE IDENTIFIED AS THE FOUNDATION FOR A CANADIAN RESEARCH AGENDA: EffectivenessSafetyResource and health services utilizationKnowledge translationDeveloping integrative oncology models Research is needed within each priority area from a range of different perspectives (for example, patient, practitioner, health system) and in a way that reflects a continuum of integration from the addition of a single complementary intervention within conventional cancer care to systemic change. Strategies to implement a Canadian integrative oncology research agenda were identified, and working groups are actively developing projects in line with those strategic areas. Of note is the intention to develop a national network for integrative oncology research and knowledge translation.
CONCLUSIONS: The identified research priorities reflect the needs and perspectives of a spectrum of integrative oncology stakeholders. Ongoing stakeholder consultation, including engagement from new stakeholders, is needed to ensure appropriate uptake and implementation of a Canadian research agenda.

Entities:  

Keywords:  Canada; Integrative oncology; cam; complementary medicine; consensus development; research priorities

Year:  2013        PMID: 23904767      PMCID: PMC3728057          DOI: 10.3747/co.20.1378

Source DB:  PubMed          Journal:  Curr Oncol        ISSN: 1198-0052            Impact factor:   3.677


  15 in total

1.  Priorities for research in complementary medicine.

Authors:  D Melchart; E Ernst
Journal:  J R Soc Med       Date:  2001-11       Impact factor: 5.344

Review 2.  Integrative oncology in North America.

Authors:  Stephen M Sagar
Journal:  J Soc Integr Oncol       Date:  2006

3.  Evidence-based clinical practice guidelines for integrative oncology: complementary therapies and botanicals.

Authors:  Gary E Deng; Moshe Frenkel; Lorenzo Cohen; Barrie R Cassileth; Donald I Abrams; Jillian L Capodice; Kerry S Courneya; Trish Dryden; Suzanne Hanser; Nagi Kumar; Dan Labriola; Diane W Wardell; Stephen Sagar
Journal:  J Soc Integr Oncol       Date:  2009

4.  Levels of commitment: exploring complementary therapy use by women with breast cancer.

Authors:  Lynda G Balneaves; Joan L Bottorff; T Gregory Hislop; Carol Herbert
Journal:  J Altern Complement Med       Date:  2006-06       Impact factor: 2.579

5.  Breast cancer patients' perspectives on and use of complementary and alternative medicine: a study by the Susan G. Komen Breast Cancer Foundation.

Authors:  John A Astin; Colleen Reilly; Cheryl Perkins; Wendy L Child
Journal:  J Soc Integr Oncol       Date:  2006

6.  Three decision-making aids: brainstorming, nominal group, and Delphi technique.

Authors:  A R McMurray
Journal:  J Nurs Staff Dev       Date:  1994 Mar-Apr

7.  Use of complementary and alternative medicine in cancer patients: a European survey.

Authors:  A Molassiotis; P Fernández-Ortega; D Pud; G Ozden; J A Scott; V Panteli; A Margulies; M Browall; M Magri; S Selvekerova; E Madsen; L Milovics; I Bruyns; G Gudmundsdottir; S Hummerston; A M-A Ahmad; N Platin; N Kearney; E Patiraki
Journal:  Ann Oncol       Date:  2005-02-02       Impact factor: 32.976

8.  Defining research priorities in complementary medicine in oncology.

Authors:  M Robotin; C Holliday; A Bensoussan
Journal:  Complement Ther Med       Date:  2012-04-23       Impact factor: 2.446

9.  A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.

Authors:  Joanna Eng; Darlene Ramsum; Marja Verhoef; Emma Guns; Joyce Davison; Richard Gallagher
Journal:  Integr Cancer Ther       Date:  2003-09       Impact factor: 3.279

10.  Principles to guide integrative oncology and the development of an evidence base.

Authors:  A M Leis; L C Weeks; M J Verhoef
Journal:  Curr Oncol       Date:  2008-08       Impact factor: 3.677

View more
  5 in total

1.  Can complementary medicine increase adherence to chemotherapy dosing protocol? A controlled study in an integrative oncology setting.

Authors:  Ilanit Shalom-Sharabi; Ofer Lavie; Noah Samuels; Lital Keinan-Boker; Efraim Lev; Eran Ben-Arye
Journal:  J Cancer Res Clin Oncol       Date:  2017-08-20       Impact factor: 4.553

2.  Effect of a patient-tailored integrative medicine program on gastro-intestinal concerns and quality of life in patients with breast and gynecologic cancer.

Authors:  Ilanit Shalom-Sharabi; Noah Samuels; Ofer Lavie; Efraim Lev; Lital Keinan-Boker; Elad Schiff; Eran Ben-Arye
Journal:  J Cancer Res Clin Oncol       Date:  2017-02-28       Impact factor: 4.553

3.  Defining research priorities for bacterial sexually transmitted infections in Canada.

Authors:  Colin Q-T Lee; Fiona Kouyoumdjian; Jennifer Christian
Journal:  Can J Public Health       Date:  2014-02-03

Review 4.  Integrating complementary and alternative medicine into cancer care: Canadian oncology nurses' perspectives.

Authors:  Tracy L Truant; Lynda G Balneaves; Margaret I Fitch
Journal:  Asia Pac J Oncol Nurs       Date:  2015 Oct-Dec

5.  Physician Attitudes and Perceptions of Complementary and Alternative Medicine (CAM): A Multicentre Italian Study.

Authors:  Massimiliano Berretta; Luca Rinaldi; Rosaria Taibi; Paolo Tralongo; Alberto Fulvi; Vincenzo Montesarchio; Giordano Madeddu; Paolo Magistri; Sabrina Bimonte; Marco Trovò; Patrizia Gnagnarella; Arturo Cuomo; Marco Cascella; Arben Lleshi; Guglielmo Nasti; Sergio Facchini; Francesco Fiorica; Raffaele Di Francia; Giuseppe Nunnari; Giovanni Francesco Pellicanò; Aurelio Guglielmino; Marco Danova; Sabrina Rossetti; Alfonso Amore; Anna Crispo; Gaetano Facchini
Journal:  Front Oncol       Date:  2020-04-28       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.